-
Eyebright Medical’s Loong Crystal PR Receives NMPA Class III Medical Device Approval
•
China-based Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050) has announced that it has received a Class III Medical Devices Certificate from the National Medical Products Administration (NMPA) for its phakic intraocular lens, Loong Crystal PR. The approval, granted with fast-track status, allows the product to be used for treating…
-
Eyebright Medical Technology Aims to Raise RMB 300 Million for Contact Lens Production Expansion
•
China-based ophthalmic medical device manufacturer, Eyebright Medical Technology Co., Ltd (SHA: 688050), has announced plans to raise up to RMB 300 million (USD 41.3 million) through a private placement of 3,787,878 shares. The capital raised will be allocated towards the construction project of a contact lens and injection mold processing…
-
Eyebright Medical Technology Plans GRD Listing on SIX Exchange to Raise RMB 1.4 Billion
•
Eyebright Medical Technology Co., Ltd (SHA: 688050), a Beijing-based company specializing in ophthalmic medical devices, is poised to issue 8,420,079 Global Depository Receipts (GRDs) on the SIX Exchange, pending approval from the Swiss bourse and regulatory filing in China. The listing is anticipated to generate a take-home amount of RMB…
-
Lee’s Pharmaceutical Subsidiary Zhaoke Ophthalmology Partners with Eyebright Medical Technology
•
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has entered into a partnership with Beijing-headquartered ophthalmic device manufacturer, Eyebright Medical Technology Co., Ltd (SHA: 688050). The collaboration aims to enhance the development and commercialization of ophthalmic drugs and medical devices. Comprehensive Collaboration in OphthalmologyUnder the…
-
Eyebright Medical Gains SIX Swiss Exchange Approval for GDR Offering
•
Beijing-based ophthalmic device maker Eyebright Medical Technology Co., Ltd (SHA: 688050) has announced receiving conditional approval from the SIX Swiss Exchange to make a public offering of an undisclosed amount of Global Depositary Receipts (GDR) on the bourse. This marks a significant step in the company’s international expansion and capital…
